ArticleCancer medicine2022

Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate-adjusted analysis at the pre-adjuvant chemotherapy timing.

Ningzhen Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.